Sounds Like a Contradiction in Terms | GenomeWeb

Blogger Matt Grosso has an idea for a nonprofit drug company. The idea would be to accept contributions for testing specific drugs and bringing them to market, Grosso says. A for-profit subsidiary could be formed to move the drugs through the approval process and the members of the company could vote to contribute their dollars to a specific drug of their choice.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.